These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
468 related articles for article (PubMed ID: 33406960)
21. Gut Microbiota as Diagnostic Tools for Mirroring Disease Progression and Circulating Nephrotoxin Levels in Chronic Kidney Disease: Discovery and Validation Study. Wu IW; Lin CY; Chang LC; Lee CC; Chiu CY; Hsu HJ; Sun CY; Chen YC; Kuo YL; Yang CW; Gao SS; Hsieh WP; Chung WH; Lai HC; Su SC Int J Biol Sci; 2020; 16(3):420-434. PubMed ID: 32015679 [TBL] [Abstract][Full Text] [Related]
22. Gut Microbiota-Dependent Trimethylamine Hsu CN; Lu PC; Lo MH; Lin IC; Chang-Chien GP; Lin S; Tain YL Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30469463 [TBL] [Abstract][Full Text] [Related]
23. The impact of gut microbiota on kidney function and pathogenesis. Mahmoodpoor F; Rahbar Saadat Y; Barzegari A; Ardalan M; Zununi Vahed S Biomed Pharmacother; 2017 Sep; 93():412-419. PubMed ID: 28654798 [TBL] [Abstract][Full Text] [Related]
24. Uremic Toxin-Producing Shivani S; Kao CY; Chattopadhyay A; Chen JW; Lai LC; Lin WH; Lu TP; Huang IH; Tsai MH; Teng CH; Wu JJ; Hsieh YH; Wang MC; Chuang EY Front Cell Infect Microbiol; 2022; 12():726256. PubMed ID: 35558102 [TBL] [Abstract][Full Text] [Related]
25. The Role of the Gut Microbiome on Chronic Kidney Disease. Sampaio-Maia B; Simões-Silva L; Pestana M; Araujo R; Soares-Silva IJ Adv Appl Microbiol; 2016; 96():65-94. PubMed ID: 27565581 [TBL] [Abstract][Full Text] [Related]
26. The interplay among gut microbiota, hypertension and kidney diseases: The role of short-chain fatty acids. Felizardo RJF; Watanabe IKM; Dardi P; Rossoni LV; Câmara NOS Pharmacol Res; 2019 Mar; 141():366-377. PubMed ID: 30639376 [TBL] [Abstract][Full Text] [Related]
27. Alteration of the gut microbiota in Chinese population with chronic kidney disease. Jiang S; Xie S; Lv D; Wang P; He H; Zhang T; Zhou Y; Lin Q; Zhou H; Jiang J; Nie J; Hou F; Chen Y Sci Rep; 2017 Jun; 7(1):2870. PubMed ID: 28588309 [TBL] [Abstract][Full Text] [Related]
28. Specific Alterations of Gut Microbiota in Chinese Patients with Hypertension: A Systematic Review and Meta-Analysis. Qin Y; Zhao J; Wang Y; Bai M; Sun S Kidney Blood Press Res; 2022; 47(7):433-447. PubMed ID: 35398848 [TBL] [Abstract][Full Text] [Related]
29. Gut microbiome in chronic kidney disease: challenges and opportunities. Nallu A; Sharma S; Ramezani A; Muralidharan J; Raj D Transl Res; 2017 Jan; 179():24-37. PubMed ID: 27187743 [TBL] [Abstract][Full Text] [Related]
30. Interplay between gut microbiota, bone health and vascular calcification in chronic kidney disease. Rodrigues FG; Ormanji MS; Heilberg IP; Bakker SJL; de Borst MH Eur J Clin Invest; 2021 Sep; 51(9):e13588. PubMed ID: 33948936 [TBL] [Abstract][Full Text] [Related]
31. Gut Microbiome Characteristics in IgA Nephropathy: Qualitative and Quantitative Analysis from Observational Studies. Han S; Shang L; Lu Y; Wang Y Front Cell Infect Microbiol; 2022; 12():904401. PubMed ID: 35656030 [TBL] [Abstract][Full Text] [Related]
32. The Impact of CKD on Uremic Toxins and Gut Microbiota. Rysz J; Franczyk B; Ławiński J; Olszewski R; Ciałkowska-Rysz A; Gluba-Brzózka A Toxins (Basel); 2021 Mar; 13(4):. PubMed ID: 33807343 [TBL] [Abstract][Full Text] [Related]
33. Gut Microbiota-Dependent Trimethylamine N-Oxide Associates With Inflammation in Common Variable Immunodeficiency. Macpherson ME; Hov JR; Ueland T; Dahl TB; Kummen M; Otterdal K; Holm K; Berge RK; Mollnes TE; Trøseid M; Halvorsen B; Aukrust P; Fevang B; Jørgensen SF Front Immunol; 2020; 11():574500. PubMed ID: 33042155 [TBL] [Abstract][Full Text] [Related]
34. Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis. Rukavina Mikusic NL; Kouyoumdzian NM; Choi MR Pflugers Arch; 2020 Mar; 472(3):303-320. PubMed ID: 32064574 [TBL] [Abstract][Full Text] [Related]
35. Link between gut microbiota dysbiosis and chronic kidney disease. Noce A; Marchetti M; Marrone G; Di Renzo L; Di Lauro M; Di Daniele F; Albanese M; Di Daniele N; De Lorenzo A Eur Rev Med Pharmacol Sci; 2022 Mar; 26(6):2057-2074. PubMed ID: 35363356 [TBL] [Abstract][Full Text] [Related]
36. Integrative metagenomic and metabolomic analyses reveal severity-specific signatures of gut microbiota in chronic kidney disease. Wu IW; Gao SS; Chou HC; Yang HY; Chang LC; Kuo YL; Dinh MCV; Chung WH; Yang CW; Lai HC; Hsieh WP; Su SC Theranostics; 2020; 10(12):5398-5411. PubMed ID: 32373220 [TBL] [Abstract][Full Text] [Related]
37. [Gut microbiota in renal transplant recipients, patients with chronic kidney disease and healthy subjects]. Guirong YE; Minjie Z; Lixin YU; Junsheng YE; Lin Y; Lisha S Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1401-1408. PubMed ID: 30613005 [TBL] [Abstract][Full Text] [Related]
38. Intestinal Microbiota in Type 2 Diabetes and Chronic Kidney Disease. Sabatino A; Regolisti G; Cosola C; Gesualdo L; Fiaccadori E Curr Diab Rep; 2017 Mar; 17(3):16. PubMed ID: 28271466 [TBL] [Abstract][Full Text] [Related]
39. Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease. Tang WH; Wang Z; Kennedy DJ; Wu Y; Buffa JA; Agatisa-Boyle B; Li XS; Levison BS; Hazen SL Circ Res; 2015 Jan; 116(3):448-55. PubMed ID: 25599331 [TBL] [Abstract][Full Text] [Related]
40. The Specific Alteration of Gut Microbiota in Diabetic Kidney Diseases-A Systematic Review and Meta-Analysis. Wang Y; Zhao J; Qin Y; Yu Z; Zhang Y; Ning X; Sun S Front Immunol; 2022; 13():908219. PubMed ID: 35784273 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]